Back to Search
DAVID FRY, MD
MD
Diagnostic Radiology Physician
NPI: 1992723332IndividualAccepts Medicare
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
053431(MI)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Class of 1988
Research & Publications (20)
A systems approach to the prevention of surgical infections.
PMID 19281898·Surg Clin North Am·2009
6-review
Adverse outcomes in surgery: redefinition of postoperative complications.
PMID 19246026·Am J Surg·2009
8-other
Combining administrative and clinical data to stratify surgical risk.
PMID 17968182·Ann Surg·2007
8-other
Randomized control trial of effects of a 10-week inspiratory muscle training program on measures of pulmonary function in persons with multiple sclerosis.
PMID 18172412·J Neurol Phys Ther·2007
2-rct
The hazards of using administrative data to measure surgical quality.
PMID 17120944·Am Surg·2006
4-observational
Utilizing peptide structures as keys for unlocking challenging targets.
PMID 17017997·Mini Rev Med Chem·2006
6-review
Development of E3-substrate (MDM2-p53)-binding inhibitors: structural aspects.
PMID 16338385·Methods Enzymol·2005
8-other
Targeting protein-protein interactions for cancer therapy.
PMID 16283145·J Mol Med (Berl)·2005
6-review
Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts.
PMID 15542782·Mol Cancer Ther·2004
7-preclinical
Hapten immobilization for antibody sensing using a dynamic modification protocol.
PMID 18968473·Talanta·2001
8-other
Cell cycle and biochemical effects of PD 0183812. A potent inhibitor of the cyclin D-dependent kinases CDK4 and CDK6.
PMID 11278443·J Biol Chem·2001
7-preclinical
Site-directed irreversible inhibitors of the erbB family of receptor tyrosine kinases as novel chemotherapeutic agents for cancer.
PMID 10888032·Anticancer Drug Des·2000
6-review
Screening algorithms to assess the accuracy of present-on-admission coding.
PMID 19234617·Perspect Health Inf Manag·2009
8-other
Opportunities and challenges of developing peptide drugs in the pharmaceutical industry.
PMID 19400268·Adv Exp Med Biol·2009
8-other
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors.
PMID 19221754·Cancer Chemother Pharmacol·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11800 E TWELVE MILE ROAD
WARREN, MI 48093 - Phone
- (586) 573-5060
Quick Facts
- NPI
- 1992723332
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile